Published in Neuro Endocrinol Lett on December 13, 2006
Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res (2009) 1.19
Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology (2012) 1.19
Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis. Psychiatry Res (2013) 0.86
rTMS strategies for the study and treatment of schizophrenia: a review. Int J Neuropsychopharmacol (2008) 0.82
Changes in plasticity across the lifespan: cause of disease and target for intervention. Prog Brain Res (2013) 0.79
Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date. Innov Clin Neurosci (2015) 0.78
High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series. J ECT (2011) 0.78
Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes. Schizophr Bull (2016) 0.75
Efficacy Towards Negative Symptoms and Safety of Repetitive Transcranial Magnetic Stimulation Treatment for Patients with Schizophrenia: A Systematic Review. Shanghai Arch Psychiatry (2017) 0.75
European mental health policy: opportunities for science and innovation, challenges for implementation. Eur J Public Health (2011) 2.06
Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs (2006) 1.54
ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophr Res (2007) 1.49
Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus. Biol Psychiatry (2012) 1.47
Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev (2008) 1.35
Beyond memory, navigation, and inhibition: behavioral evidence for hippocampus-dependent cognitive coordination in the rat. J Neurosci (2005) 1.26
Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci (2012) 1.17
Reduced subgenual cingulate volumes in mood disorders: a meta-analysis. J Psychiatry Neurosci (2008) 1.08
Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry (2008) 1.07
The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett (2004) 1.03
Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations. Neuropsychobiology (2007) 1.00
Amygdala volumes in mood disorders--meta-analysis of magnetic resonance volumetry studies. J Affect Disord (2008) 0.99
White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: a two-center high-risk study. J Psychiatr Res (2010) 0.99
Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis. World J Biol Psychiatry (2011) 0.99
Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. World J Biol Psychiatry (2011) 0.98
The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuro Endocrinol Lett (2006) 0.98
Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study. J Psychiatr Pract (2012) 0.97
Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression. Neuro Endocrinol Lett (2013) 0.96
Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. J Psychiatr Res (2006) 0.92
The application of vagus nerve stimulation and deep brain stimulation in depression. Neuropsychobiology (2011) 0.90
Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord (2012) 0.90
The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol (2010) 0.90
Medial frontal and dorsal cortical morphometric abnormalities are related to obsessive-compulsive disorder. Neurosci Lett (2009) 0.88
Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics. Neuropsychobiology (2011) 0.88
EEG source analysis in obsessive-compulsive disorder. Clin Neurophysiol (2011) 0.88
Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol (2012) 0.87
LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia. Neuropsychobiology (2008) 0.87
Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study. Eur Arch Psychiatry Clin Neurosci (2012) 0.87
Subgenual cingulate volumes in offspring of bipolar parents and in sporadic bipolar patients. Eur Arch Psychiatry Clin Neurosci (2009) 0.86
Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study. Neurochem Res (2010) 0.86
The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol Biochem Behav (2005) 0.86
Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy. Neuro Endocrinol Lett (2008) 0.85
Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics. Neuro Endocrinol Lett (2011) 0.84
Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. J Affect Disord (2009) 0.83
Prospective study of hippocampal volume and function in human subjects treated with corticosteroids. Eur Psychiatry (2006) 0.83
Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia. Neuro Endocrinol Lett (2006) 0.83
Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up. Neuro Endocrinol Lett (2006) 0.82
Genetic variation in FOXP2 alters grey matter concentrations in schizophrenia patients. Neurosci Lett (2011) 0.81
Regional brain metabolism as the predictor of performance on the Trail Making Test in schizophrenia. A 18FDG PET covariation study. Neuro Endocrinol Lett (2006) 0.81
Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology (Berl) (2012) 0.80
Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. Psychopharmacology (Berl) (2007) 0.80
An analysis of spontaneous behavior following acute MDMA treatment in male and female rats. Neuro Endocrinol Lett (2007) 0.80
Age- and sex-dependent laterality of rat hippocampal cholinergic system in relation to animal models of neurodevelopmental and neurodegenerative disorders. Neurochem Res (2004) 0.80
Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study. J Clin Psychiatry (2014) 0.80
Ziprasidone-induced galactorrhea: a case report. Neuro Endocrinol Lett (2005) 0.80
Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats. Pharmacol Biochem Behav (2010) 0.80
Planum temporale analysis via a new volumetric method in autoptic brains of demented and psychotic patients. Curr Alzheimer Res (2009) 0.80
The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801. Neuropharmacology (2006) 0.80
Dementia in a patient with Fahr's syndrome. Neuro Endocrinol Lett (2008) 0.80
Language lateralization in monozygotic twins discordant and concordant for schizophrenia. A functional MRI pilot study. Eur Psychiatry (2007) 0.78
The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study. J Psychiatr Res (2011) 0.78
Hyperprolactinemia after low dose of amisulpride. Neuro Endocrinol Lett (2004) 0.78
Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders? Ann Clin Psychiatry (2007) 0.78
The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study. Neuro Endocrinol Lett (2007) 0.78
Why negative meta-analyses may be false? Eur Neuropsychopharmacol (2013) 0.77
Antidepressant monotherapy compared with combinations of antidepressants in the treatment of resistant depressive patients: a randomized, open-label study. Int J Psychiatry Clin Pract (2012) 0.77
Relapse prevention in schizophrenia: does group family psychoeducation matter? One-year prospective follow-up field study. Int J Psychiatry Clin Pract (2006) 0.77